Clinics Offer Semaglutide and Tirzepatide Weight Loss Programs

Medical weight loss programs using the GLP-1 medications semaglutide and tirzepatide are being offered under physician supervision at Florida Aesthetics and Wellness in Tampa, Florida, and VitaleHEALTH in Flower Mound and Carrollton, Texas. Semaglutide (Ozempic, Wegovy) is an FDA-approved GLP-1 receptor agonist that reduces appetite and improves satiety at a biological level. Tirzepatide (Mounjaro, Zepbound) is a dual-action GIP/GLP-1 medication. In clinical trials, patients on semaglutide lost an average of 15% of body weight, and patients on tirzepatide lost an average of about 21% of body weight over 72 weeks.

Tirzepatide is described as the newest and most effective FDA-approved weight loss medication available, with a dual-action GIP/GLP-1 mechanism that produced a level of weight reduction not previously seen with medication alone. It is especially effective for patients with insulin resistance, Type 2 diabetes, or those seeking maximum efficacy. Semaglutide curbs appetite and helps patients feel full longer, so they eat less without constant hunger.

Both clinics offer physician-supervised programs. Florida Aesthetics and Wellness's program includes monthly check-ins, dose titration, metabolic monitoring, and behavioral coaching. VitaleHEALTH's monthly program includes physician consultation and medical evaluation, lab work review, prescription medication, monthly follow-up visits, and dose adjustments. VitaleHEALTH prices the all-inclusive semaglutide program at $349 per month and the tirzepatide program at $499 per month, with straightforward self-pay pricing and the option to cancel anytime.

Semaglutide and tirzepatide are administered as once-weekly injections that patients can self-administer at home with a small needle. The most common side effects are mild and digestive, such as nausea, especially early on, and they usually improve over time.